Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MEDVidi vs Steady State Health

MEDVidi
Graded #384

Higher grade

vs+3.1000000000000014
Steady State Health
Graded #451

Lower grade

The verdict

MEDVidi takes it — 58/100 to 54.9/100.

MEDVidi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MEDVidi is a US telehealth platform whose licensed providers evaluate patients and prescribe GLP-1 weight-management medications, including brand-name Zepbound (tirzepatide) and Wegovy (semaglutide), plus…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationMEDVidi +13
53
40
Clinical oversightSteady State Health +1
77
78
Labs & monitoringMEDVidi +10
62
52
FulfillmentSteady State Health +6
59
65
Contract termsEven
55
55
MEDVidi · left barSteady State Health · right bar

The numbers

MetricMEDVidiSteady State Health
WeighScore58/10054.9/100
GradeCC
Scorecard rank#384#451
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not published2 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
MEDVidi

Graded #384 · C

Strengths

  • Licensed providers can prescribe brand-name Zepbound and Wegovy
  • Transparent flat consultation fees (195 dollar initial, 159 dollar follow-up)
  • Prescriptions sent to the patient's pharmacy of choice, so insurance can be used

Where it loses points

  • Consult-fee model: medication is not included and its cost is separate
  • No medication pricing is published
  • State list is shown as a map rather than enumerated
Steady State Health

Graded #451 · C

Strengths

  • Prescribes semaglutide or tirzepatide within a perimenopause and menopause hormone-and-metabolic care plan
  • Care delivered by a named women's-health nurse practitioner (Josie Cowburn, DNP, FNP-C)
  • Transparent flat program fee from $139/mo, with a $99/mo standalone GLP-1 support option

Where it loses points

  • Available only to Oregon and Washington residents
  • GLP-1 medication is billed separately by the pharmacy and not included in the program fee
  • Dispensing pharmacy is not publicly named

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard